SPRY Next Earnings Date Notes

— ARS Pharmaceuticals (NASDAQ: SPRY) is a biopharmaceutical company focused on developing treatments for severe allergic reactions, with its lead product candidate, neffy™, representing a needle-free, intranasal epinephrine spray aimed at treating Type I allergic reactions, including anaphylaxis. The company's core mission is to provide a safer, more accessible alternative for those in need of emergency epinephrine administration, addressing a key unmet need in the allergy treatment landscape. Investors should pay close attention to updates regarding neffy’s regulatory status, particularly U.S. FDA and European EMA review timelines, as approval is a major value driver. In addition to regulatory milestones, keep track of cash runway, R&D expenses, and commercialization plans in anticipation of approval. Metrics such as strategic partnerships, prescriber and patient adoption rates, and post-approval manufacturing capabilities will also become increasingly important. On the earnings call, listen for management's commentary on FDA feedback, progress on launch preparations, and financial discipline, as these will provide insights into SPRY's prospects for long-term growth & success in a competitive market. The next confirmed earnings date for SPRY is 3/9/2026 7:00 am.

SPRY Next Earnings Date FAQ

On this page we presented the SPRY Next Earnings Date information for ARS Pharmaceuticals along with recent past earnings dates. For Q3 of 2025, SPRY reported earnings of -0.520/share, with the earnings report taking place on 11/10/2025. For Q2 of 2025, SPRY reported earnings of -0.460/share, with the earnings report taking place on 8/13/2025. For Q1 of 2025, SPRY reported earnings of -0.350/share, with the earnings report taking place on 5/14/2025. For Q4 of 2024, SPRY reported earnings of 0.480/share, with the earnings report taking place on 3/20/2025. For Q3 of 2024, SPRY reported earnings of -0.200/share, with the earnings report taking place on 11/13/2024. And with these past earnings dates behind SPRY, investors can look ahead to the next confirmed earnings date of 3/9/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as ARS Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to ARS Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research ARS Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next SPRY earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up SPRY's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the SPRY next earnings date.